Key result
Endothelial Panx1 overexpression increases infarct size and impairs post-stroke blood flow recovery in female mice.
Why the study?
Having previously shown that endothelial cell Panx1 deletion reduces ischemic stroke infarct volume and cerebral arterial myogenic reactivity, researchers hypothesized that increased endothelial cell Panx1 expression would worsen ischemic stroke outcomes.
Does endothelial cell Panx1 overexpression worsen ischemic stroke outcomes in a sex-dependent manner in mice?
Does endothelial cell Panx1 overexpression worsen ischemic stroke outcomes in a sex-dependent manner in mice?
Endothelial cell Panx1 overexpression exacerbates ischemic stroke outcomes and impairs cerebral blood flow recovery specifically in female mice, suggesting a sex-dependent therapeutic target.
Endothelial Panx1 may represent a sex-specific target in experimental stroke; hypothesis-generating and leaves open human translation.
Ischemic stroke is a leading cause of morbidity and mortality. We have previously shown that deletion of endothelial cell (EC) Panx1 reduces ischemic stroke infarct volume and reduces cerebral arterial myogenic reactivity, which regulates cerebral blood flow. We hypothesized that EC Panx1 content dictates ischemic stroke outcome and thus increased EC Panx1 expression will worsen ischemic stroke outcomes due to exacerbated myogenic tone development and impaired cerebral blood flow recovery. To test this, we generated the Cdh5-Cre ERT2+ ROSA26-hPanx1 Tg mouse model that conditionally overexpresses the human isoform of Panx1 specifically in EC. We have found that cerebral myogenic reactivity is significantly increased with overexpression of EC Panx1 only in female mice, without alterations in peripheral vascular reactivity or blood pressure regulation. Similarly, we found that infarct size was increased and recovery of cerebral blood flow was reduced in female but not male EC Panx1 overexpressing mice. Our findings indicate a role for EC Panx1 as a mediator of ischemic stroke recovery. Furthermore, these data suggest a potential sex-dependent effect for EC Panx1, where females are more sensitive to increased EC Panx1 in cerebral vascular function and may provide a potential therapeutic target for the treatment of ischemic stroke in women.
No takes yet. Share an insight, caveat, or question.
Tomàs-Gracia et al. (2025) studied Ischemic stroke. Endothelial cell Panx1 overexpression vs. Male mice / control mice was evaluated on Cerebral myogenic reactivity, infarct size, and cerebral blood flow recovery. Endothelial cell Panx1 overexpression increased infarct size and reduced cerebral blood flow recovery in female but not male mice following ischemic stroke.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: